{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:09:18Z","timestamp":1738732158359,"version":"3.37.0"},"posted":{"date-parts":[[2023,12,22]]},"group-title":"In Review","reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,12,7]]},"abstract":"<title>Abstract<\/title>\n        <p>Monoclonal antibodies (mAbs) against Ebola virus (EBOV) glycoprotein (GP<sub>1,2<\/sub>) are the standard of care for Ebola virus disease (EVD). Anti-GP<sub>1,2<\/sub> mAbs targeting the stalk and membrane proximal external region (MPER) potently neutralize EBOV <italic>in vitro<\/italic>. However, their neutralization mechanism is poorly understood because they target a GP<sub>1,2<\/sub> epitope that has evaded structural characterization. Moreover, their <italic>in vivo<\/italic> efficacy has only been evaluated in the mouse model of EVD. Using x-ray crystallography and cryo-electron tomography of 3A6 complexed with its stalk\u2013 GP<sub>1,2<\/sub> MPER epitope we reveal a novel mechanism in which 3A6 elevates the stalk or stabilizes a conformation of GP<sub>1,2<\/sub> that is lifted from the virion membrane. In domestic guinea pig and rhesus monkey EVD models, 3A6 provides therapeutic benefit at high viremia levels, advanced disease stages, and at the lowest dose yet demonstrated for any anti-EBOV mAb-based monotherapy. These findings can guide design of next-generation, highly potent anti-EBOV mAbs.<\/p>","DOI":"10.21203\/rs.3.rs-3722563\/v1","type":"posted-content","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T15:14:06Z","timestamp":1703258046000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-7451","authenticated-orcid":false,"given":"Erica","family":"Saphire","sequence":"first","affiliation":[{"name":"La Jolla Institute for Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe Li","family":"Salie","sequence":"additional","affiliation":[{"name":"Eli Lilly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunlong","family":"Ke","sequence":"additional","affiliation":[{"name":"Medical Research Council"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1648-1625","authenticated-orcid":false,"given":"Peter","family":"Halfmann","sequence":"additional","affiliation":[{"name":"University of Wisconsin - Madison"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa Evans","family":"DeWald","sequence":"additional","affiliation":[{"name":"Emergent Biosolutions"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3795-3772","authenticated-orcid":false,"given":"Sara","family":"McArdle","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Grinyo","sequence":"additional","affiliation":[{"name":"Integral Molecular"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Davidson","sequence":"additional","affiliation":[{"name":"Integral Molecular"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-7261","authenticated-orcid":false,"given":"Sharon","family":"Schendel","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Hariharan","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Norris","sequence":"additional","affiliation":[{"name":"Univeristy of Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Yu","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakravarthy","family":"Chennareddy","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-9122","authenticated-orcid":false,"given":"Xiaoli","family":"Xiong","sequence":"additional","affiliation":[{"name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Heinrich","sequence":"additional","affiliation":[{"name":"Zalgen Labs, LLC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-2667","authenticated-orcid":false,"given":"Michael","family":"Holbrook","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility, National Institutes of Health (NIH)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-3083","authenticated-orcid":false,"given":"Benjamin","family":"Doranz","sequence":"additional","affiliation":[{"name":"Integral Molecular"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-4011","authenticated-orcid":false,"given":"Ian","family":"Crozier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Hastie","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-8296","authenticated-orcid":false,"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Branco","sequence":"additional","affiliation":[{"name":"Zalgen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-6045","authenticated-orcid":false,"given":"Jens","family":"Kuhn","sequence":"additional","affiliation":[{"name":"National Institutes of Health (NIH)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Briggs","sequence":"additional","affiliation":[{"name":"Medical Research Council"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Worwa","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Davis","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9591-2621","authenticated-orcid":false,"given":"Rafi","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"year":"2020","author":"Kuhn JH","key":"ref1","unstructured":"Kuhn JH, Amarasinghe GK, Perry DL (2020) Filoviridae. in Fields Virology, Vol.\u00a01 (Emerging Viruses) (eds. Howley, P.M., Knipe, D.M. & Whelan, S.P.J.) 449\u2013503 (Wolters Kluwer\/Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, USA,"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/pathogens11030374","article-title":"Development and structural analysis of antibody therapeutics for filoviruses","volume":"11","author":"Yu X","year":"2022","unstructured":"Yu X, Saphire EO (2022) Development and structural analysis of antibody therapeutics for filoviruses. Pathogens 11:374","journal-title":"Pathogens"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1128\/JVI.72.8.6442-6447.1998","article-title":"Biochemical analysis of the secreted and virion glycoproteins of Ebola virus","volume":"72","author":"Sanchez A","year":"1998","unstructured":"Sanchez A et al (1998) Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol 72:6442\u20136447","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","article-title":"Processing of the Ebola virus glycoprotein by the proprotein convertase furin","volume":"95","author":"Volchkov VE","year":"1998","unstructured":"Volchkov VE, Feldmann H, Volchkova VA, Klenk H-D (1998) Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 95:5762\u20135767","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","article-title":"Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1","volume":"164","author":"Wang H","year":"2016","unstructured":"Wang H et al (2016) Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1. Cell 164:258\u2013268","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran K","year":"2005","unstructured":"Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643\u20131645","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee JE","year":"2008","unstructured":"Lee JE et al (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177\u2013182","journal-title":"Nature"},{"key":"ref8","first-page":"E7987","article-title":"Structure of the Ebola virus envelope protein MPER\/TM domain and its interaction with the fusion loop explains their fusion activity","volume":"114","author":"Lee J","year":"2017","unstructured":"Lee J et al (2017) Structure of the Ebola virus envelope protein MPER\/TM domain and its interaction with the fusion loop explains their fusion activity. Proc Natl Acad Sci U S A 114:E7987\u2013E7996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt ZA","year":"2016","unstructured":"Bornholdt ZA et al (2016) Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science 351:1078\u20131083","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti D","year":"2016","unstructured":"Corti D et al (2016) Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 351:1339\u20131342","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","article-title":"Longitudinal analysis of the human B cell response to Ebola virus infection","volume":"177","author":"Davis CW","year":"2019","unstructured":"Davis CW et al (2019) Longitudinal analysis of the human B cell response to Ebola virus infection. Cell 177:1566\u20131582e1517","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","article-title":"Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV","volume":"25","author":"Ehrhardt SA","year":"2019","unstructured":"Ehrhardt SA et al (2019) Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nat Med 25:1589\u20131600","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection","volume":"164","author":"Flyak AI","year":"2016","unstructured":"Flyak AI et al (2016) Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection. Cell 164:392\u2013405","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection","volume":"174","author":"Saphire EO","year":"2018","unstructured":"Saphire EO et al (2018) Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection. Cell 174:938\u2013952e913","journal-title":"Cell"},{"year":"2022","author":"Milligan JC","key":"ref15","unstructured":"Milligan JC et al (2022), Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses. Cell 185, 995\u20131007 e1018"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1010518","DOI":"10.1371\/journal.ppat.1010518","article-title":"Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region","volume":"18","author":"Schoeder CT","year":"2022","unstructured":"Schoeder CT et al (2022) Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region. PLoS Pathog 18:e1010518","journal-title":"PLoS Pathog"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2023.01.002","article-title":"Structure of the Inmazeb cocktail and resistance to Ebola virus escape","volume":"31","author":"Rayaprolu V","year":"2023","unstructured":"Rayaprolu V et al (2023) Structure of the Inmazeb cocktail and resistance to Ebola virus escape. Cell Host Microbe 31:260\u2013272e267","journal-title":"Cell Host Microbe"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41564-018-0157-z","article-title":"Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region","volume":"3","author":"Flyak AI","year":"2018","unstructured":"Flyak AI et al (2018) Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region. Nat Microbiol 3:670\u2013677","journal-title":"Nat Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41467-019-09732-7","article-title":"Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk","volume":"10","author":"King LB","year":"2019","unstructured":"King LB et al (2019) Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. Nat Commun 10:1788","journal-title":"Nat Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"17182","DOI":"10.1073\/pnas.1414164111","article-title":"Structures of protective antibodies reveal sites of vulnerability on Ebola virus","volume":"111","author":"Murin CD","year":"2014","unstructured":"Murin CD et al (2014) Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc Natl Acad Sci U S A 111:17182\u201317187","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1128\/JVI.01490-15","article-title":"Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies","volume":"89","author":"Davidson E","year":"2015","unstructured":"Davidson E et al (2015) Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies. J Virol 89:10982\u201310992","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.0708057105","article-title":"Generation of biologically contained Ebola viruses","volume":"105","author":"Halfmann P","year":"2008","unstructured":"Halfmann P et al (2008) Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A 105:1129\u20131133","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein","volume":"535","author":"Zhao Y","year":"2016","unstructured":"Zhao Y et al (2016) Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature 535:169\u2013172","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.chom.2017.12.003","article-title":"The marburgvirus-neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding","volume":"23","author":"King LB","year":"2018","unstructured":"King LB et al (2018) The marburgvirus-neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding. Cell Host Microbe 23:101\u2013109e104","journal-title":"Cell Host Microbe"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coi.2021.03.008","article-title":"Ebola virus disease: current vaccine solutions","volume":"71","author":"Tomori O","year":"2021","unstructured":"Tomori O, Kolawole MO (2021) Ebola virus disease: current vaccine solutions. Curr Opin Immunol 71:27\u201333","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/infdis\/jiy285","article-title":"Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates","volume":"218","author":"Pascal KE","year":"2018","unstructured":"Pascal KE et al (2018) Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates. J Infect Dis 218(5):S612\u2013S626","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"107583","DOI":"10.1016\/j.celrep.2020.107583","article-title":"HIV-1 envelope and MPER antibody structures in lipid assemblies","volume":"31","author":"Rantalainen K","year":"2020","unstructured":"Rantalainen K et al (2020) HIV-1 envelope and MPER antibody structures in lipid assemblies. Cell Rep 31:107583","journal-title":"Cell Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1073\/pnas.1810927115","article-title":"Influenza hemagglutinin membrane anchor","volume":"115","author":"Benton DJ","year":"2018","unstructured":"Benton DJ et al (2018) Influenza hemagglutinin membrane anchor. Proc Natl Acad Sci U S A 115:10112\u201310117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"Smith K","year":"2009","unstructured":"Smith K et al (2009) Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 4:372\u2013384","journal-title":"Nat Protoc"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4269\/ajtmh.1994.51.393","article-title":"Isolation of a strain of a Hantaan virus from a fatal case of hemorrhagic fever with renal syndrome in Slovenia","volume":"51","author":"Avsic-Zupanc T","year":"1994","unstructured":"Avsic-Zupanc T et al (1994) Isolation of a strain of a Hantaan virus from a fatal case of hemorrhagic fever with renal syndrome in Slovenia. Am J Trop Med Hyg 51:393\u2013400","journal-title":"Am J Trop Med Hyg"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4269\/ajtmh.2010.09-0636","article-title":"Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses","volume":"82","author":"Trombley AR","year":"2010","unstructured":"Trombley AR et al (2010) Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg 82:954\u2013960","journal-title":"Am J Trop Med Hyg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch WXDS","year":"2010","unstructured":"Kabsch WXDS (2010) Acta Crystallogr D Biol Crystallogr 66:125\u2013132","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing and analysis with the autoPROC toolbox","volume":"67","author":"Vonrhein C","year":"2011","unstructured":"Vonrhein C et al (2011) Data processing and analysis with the autoPROC toolbox. Acta Crystallogr D Biol Crystallogr 67:293\u2013302","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1107\/S090744491003982X","article-title":"An introduction to data reduction: space-group determination, scaling and intensity statistics","volume":"67","author":"Evans PR","year":"2011","unstructured":"Evans PR (2011) An introduction to data reduction: space-group determination, scaling and intensity statistics. Acta Crystallogr D Biol Crystallogr 67:282\u2013292","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans PR","year":"2013","unstructured":"Evans PR, Murshudov GN (2013) How good are my data and what is the resolution? Acta Crystallogr D Biol Crystallogr 69:1204\u20131214","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy AJ","year":"2007","unstructured":"McCoy AJ et al (2007) Phaser crystallographic software. J Appl Crystallogr 40:658\u2013674","journal-title":"J Appl Crystallogr"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn MD","year":"2011","unstructured":"Winn MD et al (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67:235\u2013242","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse A","year":"2018","unstructured":"Waterhouse A et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013w303","journal-title":"Nucleic Acids Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley P","year":"2004","unstructured":"Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126\u20132132","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner D","year":"2019","unstructured":"Liebschner D et al (2019) Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol 75:861\u2013877","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/1-59745-026-X:97","volume-title":"Methods in Molecular Biology, Vol. 328: New and Emerging Proteomic Techniques","author":"Folta-Stogniew E","year":"2006","unstructured":"Folta-Stogniew E (2006) Oligomeric states of proteins determined by size-exclusion chromatography coupled with light scattering, absorbance, and refractive index detectors. In: Nedelkov D, Nelson RW (eds) Methods in Molecular Biology, Vol. 328: New and Emerging Proteomic Techniques, vol 328. Humana Press, Totowa, NJ, USA, pp 97\u2013112"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/abio.1996.0345","article-title":"Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions","volume":"240","author":"Wen J","year":"1996","unstructured":"Wen J, Arakawa T, Philo JS (1996) Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions. Anal Biochem 240:155\u2013166","journal-title":"Anal Biochem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.celrep.2018.08.009","article-title":"Structural basis of pan-ebolavirus neutralization by an antibody targeting the glycoprotein fusion loop","volume":"24","author":"Murin CD","year":"2018","unstructured":"Murin CD et al (2018) Structural basis of pan-ebolavirus neutralization by an antibody targeting the glycoprotein fusion loop. Cell Rep 24:2723\u20132732e2724","journal-title":"Cell Rep"},{"key":"ref44","first-page":"e01674","article-title":"Structural basis of pan-ebolavirus neutralization by a human antibody against a conserved, yet cryptic epitope","volume":"9","author":"West BR","year":"2018","unstructured":"West BR et al (2018) Structural basis of pan-ebolavirus neutralization by a human antibody against a conserved, yet cryptic epitope. mBio 9:e01674\u2013e01618","journal-title":"mBio"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead P","year":"2017","unstructured":"Bankhead P et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:16878","journal-title":"Sci Rep"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani A","year":"2017","unstructured":"Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA (2017) cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods 14:290\u2013296","journal-title":"Nat Methods"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e59225","DOI":"10.7554\/eLife.59225","article-title":"Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers","volume":"9","author":"Wan W","year":"2020","unstructured":"Wan W et al (2020) Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers. Elife 9:e59225","journal-title":"Elife"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","article-title":"Structures and distributions of SARS-CoV-2 spike proteins on intact virions","volume":"588","author":"Ke Z","year":"2020","unstructured":"Ke Z et al (2020) Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588:498\u2013502","journal-title":"Nature"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/jsbi.1996.0013","article-title":"Computer visualization of three-dimensional image data using IMOD","volume":"116","author":"Kremer JR","year":"1996","unstructured":"Kremer JR, Mastronarde DN, McIntosh JR (1996) Computer visualization of three-dimensional image data using IMOD. J Struct Biol 116:71\u201376","journal-title":"J Struct Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jsb.2004.10.006","article-title":"TOM software toolbox: acquisition and analysis for electron tomography","volume":"149","author":"Nickell S","year":"2005","unstructured":"Nickell S et al (2005) TOM software toolbox: acquisition and analysis for electron tomography. J Struct Biol 149:227\u2013234","journal-title":"J Struct Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1073\/pnas.0409178102","article-title":"Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography","volume":"102","author":"F\u00f6rster F","year":"2005","unstructured":"F\u00f6rster F, Medalia O, Zauberman N, Baumeister W, Fass D (2005) Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography. Proc Natl Acad Sci U S A 102:4729\u20134734","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen EF","year":"2004","unstructured":"Pettersen EF et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612","journal-title":"J Comput Chem"},{"key":"ref53","first-page":"E11751","article-title":"Structure and architecture of immature and mature murine leukemia virus capsids","volume":"115","author":"Qu K","year":"2018","unstructured":"Qu K et al (2018) Structure and architecture of immature and mature murine leukemia virus capsids. Proc Natl Acad Sci U S A 115:E11751\u2013E11760","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.str.2015.06.026","article-title":"W. Advances in single-particle electron cryomicroscopy structure determination applied to sub-tomogram averaging","volume":"23","author":"Bharat TAM","year":"2015","unstructured":"Bharat TAM, Russo CJ, L\u00f6we J, Passmore LA, Scheres SH (2015) W. Advances in single-particle electron cryomicroscopy structure determination applied to sub-tomogram averaging. Structure 23:1743\u20131753","journal-title":"Structure"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/v12070753","article-title":"Kikwit Ebola virus disease progression in the rhesus monkey animal model","volume":"12","author":"Bennett RS","year":"2020","unstructured":"Bennett RS et al (2020) Kikwit Ebola virus disease progression in the rhesus monkey animal model. Viruses 12:753","journal-title":"Viruses"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.3390\/v4123511","article-title":"Standardization of the filovirus plaque assay for use in preclinical studies","volume":"4","author":"Shurtleff AC","year":"2012","unstructured":"Shurtleff AC et al (2012) Standardization of the filovirus plaque assay for use in preclinical studies. Viruses 4:3511\u20133530","journal-title":"Viruses"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3722563\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3722563\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T08:10:04Z","timestamp":1738656604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3722563\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":56,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3722563\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-025-56452-2","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,12,22]]},"subtype":"preprint"}}